How the product works:
- Activates GIP and GLP-1 receptors, stimulating insulin secretion
- Lowers fasting and postprandial blood glucose
- Slows gastric emptying and aids in weight reduction
- Improves tissue insulin sensitivity
Recommended for:
- Patients with type 2 diabetes
- Individuals with insulin resistance
- Patients with diabetes and obesity
- Those who did not achieve target glucose levels with other therapies
Research:
Clinical studies (SURPASS, 2021–2022) demonstrated Tirzepatide’s superior efficacy compared to GLP-1 analogues in lowering HbA1c and body weight.
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)